Effect of concurrent use of rh-IL-3 and rh-GM-CSF on apoptosis of HL-60 cells induced by Ara-C

J Tongji Med Univ. 1997;17(1):13-7. doi: 10.1007/BF02887994.

Abstract

The myeloid leukemic cell line HL-60 was studied by using DNA gel electrophoresis, flow cytomery, McAb C-myc, McAb Bcl-2 and CFU-L. From zero to 36 h, the apoptosis rates of 8 different phases and other indexes were observed. The results showed that with the prolonged time of drug incubation, apoptosis of HL-60 cells increased progressively. This effect can be enhanced obviously by rh-IL-3 and rh-GM-CSF. At the same time, the killed rate of leukemic cells by Ara-C induction was increased. C-myc expression was decreased and Bcl-2 expression did not display apparent change. Interestingly, the normal hemopoietic cells were not affected by these two kinds of cytokine. The theoretical basis was provided for concurrent use of rh-IL-3, rh-GM-CSF and cytotoxic drugs whose purpose is to elevate remission rate during the phase of induced remission of leukemia.

MeSH terms

  • Apoptosis / drug effects*
  • Cells, Cultured
  • Cytarabine / pharmacology
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • HL-60 Cells / drug effects
  • HL-60 Cells / pathology
  • HL-60 Cells / physiology*
  • Humans
  • Interleukin-3 / pharmacology*
  • Proto-Oncogene Proteins c-myc / biosynthesis
  • Recombinant Proteins

Substances

  • Interleukin-3
  • Proto-Oncogene Proteins c-myc
  • Recombinant Proteins
  • Cytarabine
  • Granulocyte-Macrophage Colony-Stimulating Factor